It stays in agreement with observation of Salarpour et al. which previously demonstrated that CEBPA and RUNX1 expression levels are significantly positively correlated in both AML patients and healthy volunteers, although correlation was stronger in normal control cases [27]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.